€9.68 ($10.90)

+0.18 (+1.89%)

Weekly Expected Move ±3.9%

€9 €9 €10 €10 €10

PAR · Healthcare · Medical - Care Facilities · Tech Score Strong Sell · Power 36 · €1.1B mcap · 45M float · 0.0014% daily turnover

Revenue

$5.2B +4.7% ▲

5Y CAGR: +7.0%

Gross Profit

$4.1B +3.6% ▲

5Y CAGR: +6.3%

Operating Income

$187M +1.7% ▲

5Y CAGR: +0.3%

Net Income

-$54M -0.4% ▼

EPS (Diluted)

$-0.49 +0.0% ▲

EBITDA

$600M +1.4% ▲

5Y CAGR: +2.4%

View Full Income Statement

Line Item	FY2020	FY2021	FY2022	FY2023	FY2024
Revenue	$4.0B	$4.3B	$4.7B	$5.0B	$5.2B
YoY Growth	+7.4%	+6.9%	+9.3%	+6.5%	+4.7%
Cost of Revenue	$819M	$891M	$979M	$1.1B	$1.2B
Gross Profit	$3.2B	$3.4B	$3.7B	$3.9B	$4.1B
Gross Margin	79.6%	79.3%	79.2%	78.7%	77.9%
R&D Expenses	$0	$0	$0	$0	$0
SG&A Expenses	$86M	$85M	$698M	$0	$0
Operating Expenses	$2.9B	$3.1B	$3.5B	$3.8B	$3.9B
Operating Income	$272M	$281M	$218M	$184M	$187M
Operating Margin	6.8%	6.5%	4.6%	3.7%	3.6%
Interest Expense	$129M	$129M	$165M	$205M	$215M
Income Before Tax	$103M	$185M	$88M	-$41M	-$33M
Tax Expense	$30M	$57M	$24M	-$4M	$2M
Net Income	$65M	$118M	$49M	-$54M	-$54M
Net Margin	1.6%	2.8%	1.1%	-1.1%	-1.0%
EPS (Diluted)	$0.59	$1.07	$0.45	$-0.49	$-0.49
EBITDA	$596M	$677M	$647M	$585M	$600M
Shares Outstanding	110M	110M	110M	110M	110M

Line Item	FY2022 Q4	FY2023 Q1	FY2023 Q2	FY2023 Q3	FY2023 Q4	FY2024 Q1	FY2024 Q2	FY2024 Q4
Revenue	$2.5B	$1.2B	$2.4B	$1.3B	$1.3B	$1.3B	$1.3B	$2.7B
Cost of Revenue	$2.0B	$870M	$1.9B	$962M	$932M	$922M	$922M	$2.2B
Gross Profit	$469M	$315M	$423M	$370M	$373M	$332M	$332M	$549M
Gross Margin	18.8%	26.6%	17.8%	27.8%	28.6%	26.5%	26.5%	20.1%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$374M	$21M	$380M	$33M	$8M	$20M	$20M	$262M
Operating Expenses	$364M	$279M	$345M	$314M	$354M	$300M	$300M	$428M
Operating Income	$105M	$46M	$78M	$56M	$19M	$31M	$66M	$122M
Operating Margin	4.2%	3.9%	3.3%	4.2%	1.4%	2.5%	5.2%	4.5%
Interest Expense	$96M	$0	$101M	$0	$129M	$47M	$0	$107M
Income Before Tax	$20M	-$8M	-$16M	-$18M	-$25M	-$21M	-$43M	$9M
Tax Expense	$3M	-$1M	-$2M	$600K	-$2M	-$2M	-$3M	$5M
Net Income	$6M	-$9M	-$17M	-$3M	-$33M	-$22M	-$22M	-$11M
Net Margin	0.2%	-0.7%	-0.7%	-0.2%	-2.6%	-1.7%	-1.7%	-0.4%
EPS (Diluted)	$0.05	$-0.08	$-0.16	$-0.03	$-0.29	$-0.20	$-0.20	$-0.10
EBITDA	$319M	$87M	$292M	$271M	$120M	$72M	$72M	$330M
Shares Outstanding	110M	110M	110M	105M	115M	110M	110M	110M

GDS.PA PAR